Pimride (PIM) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – September 1, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – September 1, 2022) – LBank Exchange, a global digital asset…
Shandong Weifang Will Gather Kites from All Over the World for an Online Sky Party…
Harley Street, UK – London Cartilage Clinic, founded and led by Prof. Paul Lee, introduces…
TOKYO, Sep 1, 2022 – (JCN Newswire) – Mitsubishi Heavy Industries, Ltd. (MHI) and Mitsubishi…
TOKYO, Sep 1, 2022 – (JCN Newswire) – Keppel Infrastructure Holdings Limited (Keppel Infrastructure), through…
MUMBAI, India–(BUSINESS WIRE)–Indian Oil Corporation Limited, India’s flagship national energy major, has collaborated with Fiserv,…
VIENNA & PARIS–(BUSINESS WIRE)–#Audio–GrAI Matter Labs (GML), a pioneer of brain-inspired ultra-low latency and high…
The 7900q Thin & Zero Client Series Enhances the 10ZiG Lineup of Hardware for Customers…
TOKYO, Sep 1, 2022 – (JCN Newswire) – Fujitsu today announced a comprehensive update to…
HONG KONG, Sep 1, 2022 – (ACN Newswire) – GOME Retail Holdings Limited (HKEX Code:…
Singapore, Sep 1, 2022 – (ACN Newswire) – The Asia Video Industry Association (AVIA) welcomed…
HONG KONG, Sep 1, 2022 – (ACN Newswire) – As pharmaceutical reformation is underway, the…
SINGAPORE, Sep 1, 2022 – (ACN Newswire) – TransformHub, a Singapore-headquartered end-to-end digital solutions provider…
DALLAS–(BUSINESS WIRE)–#CopartEarnings–Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the fourth…
Secured funding of approximately $185 million in gross proceeds through the merger with OACB (the…
Secured funding of approximately $185 million in gross proceeds through the merger with OACB (the…
AUSTIN, Texas, Aug. 31, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc., (Nasdaq: MTEM, “Molecular Templates”…
WEST CHESTER, Pa., Aug. 31, 2022 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA),…
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today…
Imsidolimab (anti-IL-36 receptor antagonist) did not demonstrate improvement over placebo in the primary endpoint and…